Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

AI-powered facial biomarker screening for early dementia detection

Reference number
Coordinator Cognes Medical Solutions AB
Funding from Vinnova SEK 500 000
Project duration November 2025 - August 2026
Status Completed
Venture Innovative Startups
Call Innovative Startups 2025

Important results from the project

The project resulted in an improved AI model, app, web platform and secure data flows for research use. Cognes also developed study protocols, technical documentation and collaboration processes, and refined the call for proposals for pharmaceutical companies, CROs and research organizations.

Expected long term effects

The results may contribute to more accessible and objective prescreening in dementia research. In the longer term, the technology may facilitate earlier identification of suitable study participants, broaden participation, and streamline recruitment and follow-up in clinical trials.

Approach and implementation

The work was organized into coordinated tracks for model development, app and platform, data management, study preparation, intellectual property rights, and market analysis. Research partners and external experts continuously contributed clinical, technical, and commercial perspectives.

External links

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 18 September 2026

Reference number 2025-02493